Bard IVC Filters
SAFETY ALERT – Affected Bard IVC Filters:
- Bard Recovery filters (2003-2005)
- Bard G2 filters (2005 – present)
The U.S. Food and Drug Administration has issued a safety alert regarding the risk presented by long term use of interior vena cava (IVC) filters, which are intended to catch blood clots before they can reach a patient’s heart and lungs. Patients with IVC filters are typically those with a history of blood clots in their legs, those diagnosed with deep vein thrombosis (DVT), trauma victims, recent surgery patients or patients who have immobilizing conditions.
The IVC filter manufacturer Bard Peripheral Vascular has experienced a very high failure rate. Its Bard Recovery Filter has a reported 25% failure rate; the Bard G2 filter has a 12% failure rate. The risk presented by these filters include device migration, embolization (detachment of the device) perforation of the IVC and filter fracture.
Fractured filters could cause rapid heart beat, fluid build up and even sudden death. Our firm is currently reviewing claims involving filter injuries or potential injuries. If you or someone you know has received a Bard IVC Filter, we would like to help.
There is Only a LIMITED Time to File Your Claim.
Contact us at 1-888-848-8991 or info@goldenbergheller.com.
Join us on
Follow us on 
RSS Feed 